在2级过敏反应后,在 cetuximab 重新挑战中使用前期药物治疗策略
Molly Lofy1, Lindsey Jung1, Elizabeth Dow-Hillgartner1
1Department of Pharmacy, University of Wisconsin Hospitals and Clinics, Madison, USA.
概括
在输液反应后,Cetuximab的再发作可能是通过增强的前期治疗策略来实现的. 增加德克萨米他松和法莫蒂丁的剂量,以及更慢的输液速度,可以减轻癌症患者过敏症的风险.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 塞图西马布是一种IgG1单克隆抗体,用于治疗转移性结直肠癌和头癌.
- 过敏反应需要前期治疗,但反应后的再挑战策略缺乏明确的指导.
研究的目的:
- 为了描述2级过敏反应后成功的 cetuximab 重新挑战.
- 为了确定风险因素,并为 cetuximab 重新挑战提议预治疗策略.
主要方法:
- 两名患有2级过敏反应的患者重新接受了增加前期药物 (德克萨米他松,法莫蒂丁,二胺,乙氨基) 和降低输液速率的治疗.
- 在初始输注后1-2周发生了重新挑战.
主要成果:
- 两位患者都成功完成了塞图西马布治疗,没有进一步的输液反应.
- 增强的前期治疗和降低的输液率是有效的.
结论:
- 男性性别和特定于 cetuximab 的 IgE 是输液反应的危险因素.
- 增加使用德克萨米他和法莫蒂丁的前期治疗,以及降低输液速率,可以使成功的 cetuximab 重新挑战.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
216
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
216
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
170
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
170
Allergic Drug Reactions
850
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
850
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
310
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
310
Cardiac Catheterization IV: Nursing Management
29
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
29
Allergic Reactions
27.6K
Overview
27.6K


